Senkyunolide A interrupts TRAF6-HDAC3 interaction to epigenetically suppress c-MYC and attenuate cholestatic liver injury
We highlight the therapeutic potential of SenA in cholestatic liver diseases by elucidating its role in epigenetic regulation.
Authors
- Zhi Ma (ORCID: https://orcid.org/0000-0002-5803-4954)
- Runping Liu (ORCID: https://orcid.org/0000-0001-8873-5252)
- Xiaoyong Xue
- K. Xie
- Yajie Cai
- Feng Gao (ORCID: https://orcid.org/0000-0002-8366-3605)
- Yajing Li (ORCID: https://orcid.org/0000-0002-7118-4658)
- Jiaorong Qu
- Bing Xu (ORCID: https://orcid.org/0000-0003-4325-0299)
- Xiaojiaoyang Li (ORCID: https://orcid.org/0000-0002-8997-9651)
- Kexin Jia
- Jianan Li
- Fanghong Li
- Qi Zheng (ORCID: https://orcid.org/0000-0002-0506-9133)
Institutions
- Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Journal of Advanced Research
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1016/j.jare.2025.04.002
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China